PBMs Must Use "Aggressive" Rx Cost Containment In Medicare - Rep. Thomas

Discussions about the structure of competition under a pharmacy benefit management company administered Medicare drug benefit are irrelevant if PBMs are not able to pursue "aggressive" cost containment, House Ways & Means/Health Subcommittee Chairman Thomas (R-Calif.) said during a May 11 hearing.